Top Buy
| Security | Buy | Sell | Buy (1W) | Sell (1W) ▼ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Catalent Inc. | 2 | 0 | 1 | 0 | €52.99 | €56.00 | 5.680% |
| Hutchison China MediTech Ltd ADR | 5 | 0 | 0 | 0 | €15.50 | €45.10 | 190.935% |
| AbbVie Inc. | 43 | 0 | 7 | 0 | €154.86 | €176.30 | 13.845% |
| Natural Alternat. | 19 | 1 | 1 | 0 | €5.15 | - | - |
| Avadel Pharmaceuticals plc ADR | 1 | 0 | 0 | 0 | €15.10 | €23.00 | 52.318% |
| Sarepta Therapeutics | 13 | 0 | 7 | 0 | €138.50 | €180.00 | 29.964% |
| Genmab A/S | 1 | 0 | 1 | 0 | €236.80 | €250.00 | 5.574% |
| Acadia Pharmaceuticals | 30 | 1 | 0 | 0 | €16.03 | €31.00 | 93.470% |
| MacroGenics Inc. | 13 | 0 | 0 | 0 | €3.95 | €12.42 | 214.231% |
| Viatris Inc. | 3 | 0 | 1 | 0 | €10.05 | €12.25 | 21.891% |
| Biocryst Pharmaceuticals | 9 | 0 | 0 | 0 | €5.91 | €11.05 | 86.797% |
| Alnylam Pharmace. | 47 | 0 | 0 | 0 | €236.10 | €256.11 | 8.474% |
| Fagron N.V. | 1 | 0 | 0 | 0 | €18.14 | €20.00 | 10.254% |
| TG Therapeutics Inc. | 22 | 3 | 0 | 0 | €18.41 | €28.06 | 52.475% |
| Astellas Pharma Inc. | 2 | 0 | 0 | 0 | €9.31 | €16.00 | 71.784% |
| Aurinia Pharmaceuticals Inc. | 1 | 1 | 0 | 0 | €5.21 | €8.75 | 68.075% |
| Eli Lilly Corp. | 79 | 0 | 11 | 0 | €869.90 | €900.00 | 3.460% |
| Sanofi S.A. ADR | 9 | 0 | 0 | 0 | €46.40 | - | - |
| MorphoSys AG | 7 | 0 | 0 | 0 | €67.70 | €65.00 | -3.988% |
| Dr. Reddy's Laboratories Ltd. ADR | 6 | 1 | 0 | 0 | €71.00 | €74.65 | 5.134% |
| Emergent Biosolutions Inc. | 4 | 3 | 0 | 0 | €8.01 | €7.45 | -6.956% |
| Eledon Pharmaceuticals Inc. | 6 | 0 | 0 | 0 | €2.22 | €12.21 | 450.041% |
| AstraZeneca plc | 2 | 0 | 0 | 0 | €143.10 | €165.00 | 15.304% |
| Knight Therapeutics | 1 | 0 | 0 | 0 | €3.86 | €10.00 | 159.067% |
| VBI Vaccines Inc. | 1 | 0 | 0 | 0 | €0.69 | €3.00 | 337.318% |